Estimated Cancer Prevalence by Cancer Site and Gender, New York City, 2020

Source: New York State Cancer Registry

Site of Cancer	Diagnosed in Last 5 Years			Ever Diagnosed
	Males and Females	Males	Females	Males and Females	Males	Females
All Invasive Malignant Tumors	148,700	69,600	79,100	442,300	198,000	244,300
Oral cavity and pharynx	3,400	2,200	1,200	9,600	5,800	3,800
Esophagus	600	400	200	1,400	900	500
Stomach	2,800	1,500	1,200	7,300	4,000	3,300
Colorectal	12,300	6,300	6,000	38,800	18,400	20,400
Liver / intrahepatic bile duct	2,300	1,600	700	4,700	3,300	1,400
Pancreas	1,900	900	1,000	3,400	1,600	1,800
Larynx	900	700	200	3,200	2,400	700
Lung and bronchus	10,600	4,800	5,800	20,200	9,100	11,200
Melanoma of the skin	4,100	2,200	1,900	14,100	6,900	7,100
Female breast			28,600			94,700
Cervix uteri			1,700			9,500
Corpus uterus and NOS			6,700			21,600
Ovary			1,900			7,000
Prostate		25,700			84,400
Testis		1,100			5,400
Urinary bladder (incl. in situ)	6,000	4,500	1,500	16,700	12,100	4,700
Kidney and renal pelvis	5,600	3,600	2,100	15,900	9,700	6,200
Brain and other central nervous system	1,400	800	600	5,600	2,900	2,700
Thyroid	8,800	2,100	6,700	29,500	6,400	23,100
Hodgkin lymphoma	1,200	600	500	6,300	3,200	3,100
Non-Hodgkin lymphomas	7,000	3,600	3,400	21,100	10,700	10,300
Myeloma	3,200	1,600	1,600	6,200	3,100	3,100
Leukemias	4,300	2,400	1,900	12,300	6,700	5,600

Notes

• Estimated number of residents alive as of January 1, 2020, diagnosed with cancer within the last 5 years or anytime in the past, respectively.
• Numbers are rounded to the nearest 100.
• Refer to https://www.naaccr.org/wp-content/uploads/2020/01/CINA12-16.v5.sec1_.pdf for a detailed description of prevalence methodology.